Connor, Clark & Lunn Investment Management (CC&L)’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
2020
Q2
$1.31M Buy
2020
Q1
$765K Buy